These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6442062)

  • 1. [The pharmacology of gold compounds].
    Juan H
    Wien Klin Wochenschr Suppl; 1984; 156():7-13. PubMed ID: 6442062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and distribution of gold compounds.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():2-6. PubMed ID: 114646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold compounds in rheumatoid arthritis: clinical-pharmacokinetic correlates.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():51-5. PubMed ID: 114649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Bröll H; Tausch G; Teherani DK
    Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of action of gold compounds].
    Vischer TL
    Wien Klin Wochenschr Suppl; 1984; 156():17-8. PubMed ID: 6442050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983.
    Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold excretion and retention during auranofin treatment: a preliminary report.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():61-7. PubMed ID: 385875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
    Furst DE
    Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of parenteral and oral gold compounds.
    Gottlieb NL
    J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A; Kunishima DH; Harralson AF; Simon TM
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.